Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 10Other hematologic neoplasm 9Lymphoid 9Breast 8Tumor-Agnostic 7Genitourinary 6Dermatologic 6Thoracic 4CNS 4Sarcoma 3Plasma cell 3Myeloid 3Gynecologic 3Gastrointestinal 1Classical hematology 1

Conditions

Neutropenia 1Mycoses 1Hematologic Neoplasms 1Febrile Neutropenia 1

Interventions

fludarabine phosphate 58Cyclophosphamide 54Epoetin Alfa 43Cyclosporine 43Busulfan 43Peripheral Blood Stem Cell Transplantation 39Mycophenolic Acid 34Darbepoetin alfa 33Antilymphocyte Serum 31Whole-Body Irradiation 30Cytarabine 30Filgrastim 29Methotrexate 26Tacrolimus 25Radiotherapy 25Melphalan 24fludarabine 21Methylprednisolone 17Cord Blood Stem Cell Transplantation 17Etoposide 14Granulocyte Colony-Stimulating Factor 13Daunorubicin 13Rivaroxaban 12apixaban 11Thiotepa 11sargramostim 10epoetin beta 10Dalteparin 10eltrombopag 9Alemtuzumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Itraconazole × Classical hematology × Clear all
NCT01706562 2013-02-20

A Study of Empirical Antifungal Therapy With Itraconazole

Janssen Korea, Ltd., Korea

Completed
138 enrolled
Classical hematologyOther hematologic neoplasm

Mycoses, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡